gastric cancer
Showing NaN - NaN of 59
NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
-
Anchorage, Alaska
- +34 more
Apr 4, 2022
Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,
Recruiting
- Metastatic Solid Tumor
- +6 more
- Surufatinib and Tislelizumab _ Part 1
- Surufatinib and Tislelizumab _ Part 2
-
Tucson, Arizona
- +17 more
Apr 1, 2022
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)
Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)
Recruiting
- Bladder Cancer
- +9 more
- CAdVEC
-
Houston, TexasBaylor St. Luke's Medical Center
Feb 17, 2022
Long-term, Non-interventional, Observational Study Following
Recruiting
- Advanced Solid Tumor
- +17 more
- Allogeneic natural killer (NK) cell
-
San Diego, California
- +3 more
Oct 15, 2021
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Gastric Cancer Trial in Worldwide (177Lu-3BP-227 (also called
Terminated
- Pancreatic Ductal Adenocarcinoma
- +7 more
- 177Lu-3BP-227 (also called 177Lu-IPN01087)
-
Houston, Texas
- +7 more
Jun 2, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)
Completed
- Gastric Cancer
- +3 more
-
Santa Monica, California
- +27 more
Jan 18, 2021
Helicobacter Pylori Genome Project (HpGP)
Terminated
- Gastric Cancer
- +2 more
-
Batesville, Arkansas
- +93 more
Dec 17, 2020
Gastric Cancer Trial in Canada, United States (S-1/Cisplatin, 5-FU/cisplatin)
Completed
- Gastric Cancer
-
Huntsville, Alabama
- +32 more
Aug 4, 2020
Stomach Cancer, Gastric Cancer Trial in Houston (drug, radiation, procedure)
Completed
- Stomach Cancer
- Gastric Cancer
- 5-Fluorouracil
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 29, 2020
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United States (FOLFOX regimen,
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FOLFOX regimen
- +5 more
-
Mobile, Alabama
- +507 more
Oct 25, 2019
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Gastric Cancer Trial in Worldwide (Ramucirumab (IMC-1211B) DP, Placebo, Paclitaxel)
Completed
- Gastric Cancer
- Ramucirumab (IMC-1211B) DP
- +2 more
-
Burbank, California
- +166 more
Sep 6, 2019
Colorectal Cancer (CRC), Gastric Cancer Trial in United States (SC-007)
Terminated
- Colorectal Cancer (CRC)
- Gastric Cancer
-
Los Angeles, California
- +6 more
Apr 25, 2018
Gastric Cancer Trial in Worldwide (Taxane, trastuzumab emtansine)
Terminated
- Gastric Cancer
- Taxane
- trastuzumab emtansine
-
Bakersfield, California
- +147 more
May 5, 2017
Motivational Counseling in Preventing Smoking Relapse After
Completed
- Bladder Cancer
- +10 more
- Smoking Prevention Usual Care
- Counseling Intervention
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 21, 2016
Head Neck Cancer, Liver Cancer, Breast Cancer Trial in United States (CUDC-101)
Completed
- Head and Neck Cancer
- +4 more
-
Encinitas, California
- +6 more
Feb 1, 2016
Esophageal Cancer, Gastric Cancer Trial in United States (drug, procedure, radiation)
Completed
- Esophageal Cancer
- Gastric Cancer
- cisplatin
- +3 more
-
Birmingham, Alabama
- +68 more
Nov 14, 2015
Esophageal Cancer, Gastric Cancer Trial in Houston (rubitecan)
Unknown status
- Esophageal Cancer
- Gastric Cancer
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Dec 3, 2013
Esophageal Cancer, Gastric Cancer Trial in Canada, United States (erlotinib HCl)
Completed
- Esophageal Cancer
- Gastric Cancer
- erlotinib hydrochloride
-
Mobile, Alabama
- +106 more
Jun 21, 2013